Breast Cancer Drug Newly Approved

Truqap to treat breast cancer

,

Drug Name: Truqap

Active Ingredient: capivasertib

Indication: An AKT inhibitor used in combination with fulvestrant for the treatment of advanced HR-positive breast cancer

Approval Date: 11/16/2023

Company: AstraZeneca

More: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-capivasertib-fulvestrant-breast-cancer

Related

Drug Practice Process Research

Elevating Healthcare Conversations through AI-Enabled CI: KAI Conversations

Drug Practice Process Research

Revolutionizing Pharmacovigilance with AI: DrugCard

Drug Practice Procedure Process Research

Solving for Precision Medicine with AI-Enabled Solutions: Tempus